Daniela Pietra

Daniela Pietra

UNVERIFIED PROFILE

Are you Daniela Pietra?   Register this Author

Register author
Daniela Pietra

Daniela Pietra

Publications by authors named "Daniela Pietra"

Are you Daniela Pietra?   Register this Author

65Publications

1583Reads

24Profile Views

Diagnosis and management of prefibrotic myelofibrosis.

Expert Rev Hematol 2018 07 22;11(7):537-545. Epub 2018 Jun 22.

a Department of Molecular Medicine , University of Pavia , Pavia , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1484280DOI Listing
July 2018

Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology.

Leuk Res 2017 07 23;58:63-72. Epub 2017 Apr 23.

Center for the Study of Myelofibrosis, Biotechnology Research Area, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.04.006DOI Listing
July 2017

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.

Am J Hematol 2016 09 4;91(9):918-22. Epub 2016 Jul 4.

Department of Experimental and Clinical Medicine and DENOTHE Excellence Center, CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24442DOI Listing
September 2016

LNK mutations in familial myeloproliferative neoplasms.

Blood 2016 07 23;128(1):144-5. Epub 2016 May 23.

Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-711150DOI Listing
July 2016

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.

Ann Hematol 2015 Nov 23;94(11):1927-8. Epub 2015 Jul 23.

Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2451-7DOI Listing
November 2015

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Haematologica 2015 Nov 6;100(11):e443-5. Epub 2015 Aug 6.

Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy Department of Molecular Medicine, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://www.haematologica.org/content/haematol/100/11/e443.fu
Web Search
http://www.haematologica.org/cgi/doi/10.3324/haematol.2015.1
Publisher Site
http://dx.doi.org/10.3324/haematol.2015.131458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825313PMC
November 2015

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.

Am J Hematol 2014 Dec 26;89(12):1107-10. Epub 2014 Sep 26.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23842DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657470PMC
December 2014

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Blood 2014 Aug 26;124(9):1513-21. Epub 2014 Jun 26.

Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-03-560227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148773PMC
August 2014

Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.

Thromb Res 2014 Jul 29;134(1):41-3. Epub 2014 Mar 29.

Division of Hematology, Department of Internal Medicine, Ospedale di Circolo & Fondazione Macchi, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2014.03.040DOI Listing
July 2014

A novel germline JAK2 mutation in familial myeloproliferative neoplasms.

Am J Hematol 2014 Jan;89(1):117-8

Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23614DOI Listing
January 2014

Somatic mutations of calreticulin in myeloproliferative neoplasms.

N Engl J Med 2013 Dec 10;369(25):2379-90. Epub 2013 Dec 10.

From CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (T.K., A.S.H., H.N., J.D.M., N.C.C.T., T.B., D.C., G.I.V., K.B., F.S., C.C., M. Six, A.S., C.B., G.S.-F., R.K.) and the Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna (H.G., B.G., M. Schalling, R.K.) - both in Vienna; and the Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo (E.R., D.P., C.M., I.C.C., E.S., V.F., C.E., L.M., C.P., M.C.), and the Department of Molecular Medicine, University of Pavia (L.M., M.C.) - both in Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311347DOI Listing
December 2013

Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.

J Clin Oncol 2013 Jun 29;31(17):e269-71. Epub 2013 Apr 29.

Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.4370DOI Listing
June 2013

COLD-PCR and innovative microarray substrates for detecting and genotyping MPL exon 10 W515 substitutions.

Clin Chem 2012 Dec 11;58(12):1692-702. Epub 2012 Oct 11.

San Raffaele Scientific Institute, Genomic Unit for the Diagnosis of Human Pathologies, Center for Translational Genomics and Bioinformatics, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.192708DOI Listing
December 2012

JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.

Am J Hematol 2012 Jul 6;87(7):746-7. Epub 2012 May 6.

Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23229DOI Listing
July 2012

Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm.

Am J Hematol 2012 Jan 31;87(1):129-30. Epub 2011 Oct 31.

Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22194DOI Listing
January 2012

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

Haematologica 2011 Mar 25;96(3):454-8. Epub 2010 Nov 25.

Division of Hematology, Department of Hematology Oncology, University of Pavia Medical School and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.033779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046278PMC
March 2011

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.

Haematologica 2011 Mar 20;96(3):367-74. Epub 2010 Dec 20.

Center for Molecular Medicine, Austrian Academy of Sciences, Lazarettgasse 14, AKH BT25.3, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.034488DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046267PMC
March 2011

Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS.

Haematologica 2011 Jan 30;96(1):167-70. Epub 2010 Sep 30.

Department of Hematology Oncology, Division of Hematology, University of Pavia Medical School and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.031831DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012782PMC
January 2011

Blast phase of essential thrombocythemia: A single center study.

Am J Hematol 2009 Oct;84(10):641-4

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21496DOI Listing
October 2009

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Blood 2009 Oct 19;114(17):3538-45. Epub 2009 Aug 19.

Department of Hematology Oncology, University of Pavia & Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-05-222331DOI Listing
October 2009

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.

J Clin Oncol 2009 Feb 22;27(5):754-62. Epub 2008 Dec 22.

Department of Hematology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.2246DOI Listing
February 2009

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

Haematologica 2008 Nov 11;93(11):1645-51. Epub 2008 Sep 11.

M.D., Division of Hematology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, viale Golgi 19, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.13346DOI Listing
November 2008

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.

Blood 2008 Feb 5;111(3):1686-9. Epub 2007 Nov 5.

Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo and University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-07-101576DOI Listing
February 2008

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.

Br J Haematol 2008 Jan 19;140(2):162-8. Epub 2007 Nov 19.

Department of Surgical Pathology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06885.xDOI Listing
January 2008

Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

J Clin Oncol 2007 Dec 12;25(35):5630-5. Epub 2007 Nov 12.

Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Viale Golgi 49, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.12.6896DOI Listing
December 2007

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

Blood 2007 Jul 10;110(2):485-9. Epub 2007 Apr 10.

Department of Hematology, University of Pavia Medical School, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-071068DOI Listing
July 2007

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

Cancer 2006 Nov;107(9):2206-11

Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia School of Medicine, Pavia, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22240
Publisher Site
http://dx.doi.org/10.1002/cncr.22240DOI Listing
November 2006

Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation.

Biochim Biophys Acta 2006 Mar 28;1763(3):330-5. Epub 2006 Feb 28.

Department of Biochemistry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2006.02.001DOI Listing
March 2006

Genetic and clinical heterogeneity of ferroportin disease.

Br J Haematol 2005 Dec;131(5):663-70

Unit of Genomics for the Diagnosis of Human Pathologies, IRCCS H. San Raffaele, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2005.05815.xDOI Listing
December 2005

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

Blood 2005 Nov 4;106(10):3374-6. Epub 2005 Aug 4.

Experimental Hematology, Department of Research, Division of Clinical Hematology, Division of Pneumology, Basel University Hospital, Switzerland.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-05-18
Publisher Site
http://dx.doi.org/10.1182/blood-2005-05-1889DOI Listing
November 2005

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Br J Haematol 2004 Sep;126(5):650-6

Division of Haematology, University of Pavia Medical School & IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.05098.xDOI Listing
September 2004